Accelerating Belgian health-tech & biopharma innovation

iStock-1093656424-web5

See what’s happening in Wallonia, Belgium

Latest news & events

Learn more
BE

Health and innovation: BioWin calls for interregional synergies to elevate Belgium’s role in Europe

    Press release

16.05.2025

Learn more
getty-images-EXn3zNVW5lo-unsplash

BioWin’s 2024 annual report is available

    Corporate

15.05.2025

Learn more
iStock-576919844

Call 46 for collaborative R&D projects now open

    Funding Innovation

06.05.2025

Learn more
fellipe-ditadi-3gE3f-LbEXw-unsplash-(1)

Pitch & Match: Register now for BioWin/Flanders Vaccine joint event

    Collaboration Innovation

25.04.2025

Learn more
Innovation-Lab-newsletter

BioWin’s Innovation Lab: Got an idea? Let’s talk.

    Collaboration Innovation

16.04.2025

Learn more

Join AWEX, BioWin and WE at BioEquity Europe

    Event

11.04.2025

Learn more

InnoSer Partners with Kabuki Syndrome Foundation to Advance Therapeutic Development for Kabuki Syndrome

    Press release

15.05.2025

Learn more
quantoom-about

Inventprise Selects Quantoom Biosciences’ Ntensify® Production Technology to Advance mRNA Vaccine Development

    Press release

15.05.2025

Learn more

Hyloris Announces Partnerships for Valacyclovir Oral Suspension Covering Canada, Australia, New Zealand and the Netherlands

    Press release

13.05.2025

Learn more
Cassy_beauty.1002-scaled

IBA launches CASSY®, a new compact radiochemistry module to enhance efficiency in radiopharmaceuticals production

    Press release

13.05.2025

Learn more
UCB2

RYSTIGGO® (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support

    Press release

09.05.2025

Learn more
1746667660539628

Full-Life Technologies Announces Appointment of Debora Barton, MD, as Chief Medical Officer

    Press release

08.05.2025

Stay informed with the BioWin newsletter

Innovate

Why join BioWin

We help simplify the path to bringing innovative ideas to life. With nearly 20 years of hands-on collaborative innovation experience, we don’t just connect companies, research centers, hospitals, and academic institutions—we’re a true partner, offering real support at every step of the research and development process.

From shaping your project to sourcing its financing and ensuring it stays on track, that’s how we give health-tech and biopharma innovations their greatest chance of success.

iStock-542576976

Connect

Why join BioWin

In a bid to increase opportunities for our members in terms of both collaboration and market expansion, we connect them to partners through regular events. We also seek to enhance sector attractiveness to source the future talent needed to create sustainable innovation across the Walloon Region.

 

iStock-530685719

Communicate

Why join BioWin

Our targeted communication strategies aim to strengthen Wallonia’s profile, while maximising our members’ presence both locally and globally.

getty-images-B1n_PGHf4JA-unsplash

Operating at the epicentre of regional health-tech & biopharma innovation

What we work on

Biopharma

iStock-1289345741

Health-tech

iStock-1125084447-web
  • From championing collaborative innovation to playing a more global role in the implementation of the sector’s industrial policy, making innovation happen is part of our DNA.
  • We aim to increase the competitiveness of the Walloon region in the biopharma and health-tech sectors by identifying and supporting strategic projects and portfolios for the benefit of our members and the patients they serve.
  • BioWin’s network of 260+ world-class organisations is an exceptional ecosystem known for both its academic excellence and robust industrial value chain in biomanufacturing, advanced therapies, nuclear medicine and medical technologies. 

Our ecosystem at a glance

Numbers

266

supported organisations

89

supported R&D projects

313,74M

€ raised by our members through public-private funding

22

job offers